Zero to Hero? Scope 3 Emissions – A Strategic Imperative for Pharma Companies Verena Ahnert Read more
Case Study Life Sciences & Pharma Developing and Operationalizing Omnichannel Capabilities in the Pharmaceutical Market November 12, 2025
Video / Webinar Life Sciences & Pharma Navigating China's Volume-Based Procurement in the Pharma Industry August 27, 2025
Executive Insights Life Sciences & Pharma L.E.K. Consulting’s Clinical and eClinical Pharma Services Outlook June 13, 2025
Case Study Life Sciences & Pharma Unlocking the Potential of Next-Generation PROTACs: A Strategic Roadmap for R&D Investment March 7, 2025 Our client engaged L.E.K. Consulting to develop a market overview across multiple key therapeutic areas (e.g., oncology, immunology, neuroscience) and…
Executive Insights Life Sciences & Pharma Redefining Biopharma R&D Productivity: New Insights and Strategies January 9, 2025
